FRANCISCO JAVIER
LÓPEZ LONGO
Investigador fins a 2019
Vicent
Fonollosa Pla
Publicacions en què col·labora amb Vicent Fonollosa Pla (11)
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238
-
New insight on the Xq28 association with systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2032-2038
2012
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
2011
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology